MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress » Epidemiology

Date: Sunday, October 7, 2018

Time: 1:45pm-3:15pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:45pm-3:15pm
A 15-year review of a movement disorder database in Singapore

A. Wong, S. Neo, H.L. Ng, W. Li, K.Y. Tay, W.L. Au, L. Tan (Singapore, Singapore)

1:45pm-3:15pm
A nationwide epidemiological study of Parkinson’s disease in Korea using national health insurance database

WW. Lee, B. Jeon, BK. Kim, HJ. Kim (Seoul, Republic of Korea)

1:45pm-3:15pm
Anemia in men and increased Parkinson’s disease risk: A population-based cohort study using big data

V. Rozani, N. Giladi, B. El-Ad, T. Gurevich, J. Tsamir, B. Hemo, C. Peretz (Tel Aviv, Israel)

1:45pm-3:15pm
Antihypertensive medications have protective associations with PD outcomes in PD-hypertension

V. Kotagal (Ann Arbor, MI, USA)

1:45pm-3:15pm
Clinical Characteristics of Functional Movement Disorders: A Clinic-Based Study

J. Park (Goyang, Republic of Korea)

1:45pm-3:15pm
Does having more children really delay Parkinson’s age of onset in women?

M. MacAskill, D. Myall, T. Pitcher, T. Melzer, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)

1:45pm-3:15pm
Droxidopa and Midodrine Treatment Persistence in Patients with Orthostatic Hypotension

S. Kymes, K. Jackson, M. Widolff, C. Sullivan, L. Hewitt, S. Raj (Deerfield, IL, USA)

1:45pm-3:15pm
Economic burden of advanced Parkinson’s disease in a national sample of elderly US Medicare beneficiaries: A prevalence-based estimate

N. Dahodwala, P. Li, J. Jahnke, V. Ladage, P. Kandukuri, J. Zamudio, Y. Bao, Y. Jalundhwala, J. Doshi (Philadelphia, PA, USA)

1:45pm-3:15pm
Emergency and in-patient healthcare utilization in Parkinson’s disease

M. Mackenzie, G. Al Momen, A. Yu, K. Sundvick, J. Wright, A. Shiu, S. Appel-Cresswell (Vancouver, BC, Canada)

1:45pm-3:15pm
Factors associated with Exercise Behaviour in Australians with Parkinson’s disease

D. Lee, N. Löfgren, J. Bampton, C. Canning, S. Paul (Lidcombe, Australia)

1:45pm-3:15pm
Incidence of Parkinson’s disease: Pooled analysis of six high-quality incidence studies with long-term follow-up

A. Macleod, M. Camacho, J. Evans, C. Williams-Gray, R. Lawson, L. Forsgren, G. Alves, O.B. Tysnes, C. Counsell (Aberdeen, United Kingdom)

1:45pm-3:15pm
Inpatient care for Parkinson’s disease in Germany: Analysis of more than one million cases from the years 2010 to 2015

L. Tönges, D. Bartig, S. Muhlack, W. Jost, R. Gold, C. Krogias (Bochum, Germany)

1:45pm-3:15pm
Levodopa-induced dyskinesias in Parkinson disease: A population-based cohort study in Olmsted County, MN (1991-2010)

P. Turcano, M. Mielke, C. Stang, J. Bower, J. Parisi, J. Cutsforth Gregory, E. Ahlskog, R. Savica (Rochester, MN, USA)

1:45pm-3:15pm
Mortality from Parkinson’s disease in China: Findings from a Ten-year follow up study in Shanghai

G. Wang, G. Xu, YQ. Zhang, SD. Chen (Shanghai, China)

1:45pm-3:15pm
Outcomes of elective orthopedic surgery in Parkinson’s disease – a Nationwide study

M. Fullard, D. Thibault, A. Willis (Philadelphia, PA, USA)

1:45pm-3:15pm
Parkinson’s Disease Risk in Breast Cancer

R. Mills-Joseph (Columbus, OH, USA)

1:45pm-3:15pm
Parkinson’s Disease Psychosis Associated Comorbidities, and Mortality in the Medicare Population

D. Weintraub, A. Willis, P. Torres, A. Shim, J. Norton, K. Liu, G. Demos (Philadelphia, PA, USA)

1:45pm-3:15pm
Prevalence and characteristics of patients with progressive supranuclear palsy (PSP) in US health insurance claims data

E. Viscidi, T. Dam, M. Juneja, L. Li, H. Krzywy, S. Eaton, S. Chen, S. Hall, A. Dilley (Cambridge, MA, USA)

1:45pm-3:15pm
Prevalence and influence of co-pathologies in patients with autopsy-confirmed Lewy body disorders: A systematic review

D. Breen, E. Ravid, A. Lang, J. Miyasaki, R. Camicioli (Toronto, ON, Canada)

1:45pm-3:15pm
Prevalence of REM Sleep Behavior Disorder in Sun City, Arizona

D. Shprecher, A. Intorcia, M. Glass, J. Curry, J. Walker, B. Cutler, M. Callan, G. Serrano, N. Zhang, L. Sue, K. Davis, T. Beach (Sun City, AZ, USA)

1:45pm-3:15pm
Prevelance in the World

Tur. Djakhangir (Tashkent, Uzbekistan)

1:45pm-3:15pm
Prodromal features of Parkinson’s disease in women

K. Hughes, X. Gao, J. Baker, C. Stephen, I. Kim, L. Valeri, M. Schwarzschild, A. Ascherio (Boston, MA, USA)

1:45pm-3:15pm
Tendency towards being a “Morning person” increases risk of Parkinson’s disease: evidence from Mendelian randomisation

A. Noyce, D. Kia, K. Heilbron, J. Jepson, G. Hemani, D. Hinds, D. Lawlor, G. Davey Smith, J. Hardy, A. Singleton, M. Nalls, N. Wood (London, United Kingdom)

1:45pm-3:15pm
The Characteristics of Patients with Movement Disorders in a Diverse Inner-City Hospital

L. Nwabuobi, J. Agee, M. Ko, R. Gilbert (New York, NY, USA)

1:45pm-3:15pm
Underserved Patient Access to Movement Disorders Care: Experience from a Tertiary Academic Referral Center

A. Giacobbe, E. Dinh, O. Nguyen, A. Ramirez-Zamora, M. Okun, L. Almeida (Gainesville, FL, USA)

1:45pm-3:15pm
West Sweden Parkinson Objective Measurement Registry Study (WestPORTS)

F. Bergquist, A. Ax, A. Sjostrom, S. Wallerstedt (Gothenburg, Sweden)

« View all sessions from the 2018 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley